NHS clinicians and researchers are being invited to start mining the data generated by the large-scale genome mapping project in the UK.
First unveiled in December 2012 the 100,000 genome project, is said to be the largest initiative of its kind in the world. The aim of the initiative is to improve the understanding of how genes affect; rare inherited diseases, cancers and infectious disease, as well as guiding the development of new diagnostics and treatments.
With the sequencing of 30,000 genomes among patients with cancer and rare diseases expected to be completed by 2017. Geonomics England who themselves were only set up last year to oversee the project wants to get the research community on board as soon as possible.
The state-owned company said the Genomics England Clinical Interpretation Partnership (GeCIP) would allow the best researchers in the UK to work with the data alongside their international collaborators in a secure date centre. It wants to attract disease experts, experts in ethics and social sciences, computer scientists and health records researchers who can be formed into multidisciplinary teams focusing on areas such as rare heart disease, breast cancer and rare inherited neurological disease.
“We need a coalition of intellects to come together to interpret and use this incredible resource for the benefit of current and future patients,” said Genomics England’s chief scientist Professor Mark Caulfield.
This project was set up with an initial funding pot of £164, in combination with a promise from Prime Minister David Cameron of a further £300 million over the next four years.
In the past month Geonomics England has identified short list of ten companies, which include the likes of; Illumina, Qiagen Congenica and Lockheed Martin, with the latter in the running to provide variant annotation and clinical interpretation services for this project.
“We want to make the UK the best place in the world to discover 21st century medicines which is why we have invested in the 100,000 Genomes Project,”
“Now we need the expertise of researchers and NHS professionals to interpret the data from the project so we get maximum benefit for patients and their families.” Said Life Sciences Minister George Freeman.
PiR Resourcing leaders in senior life science resourcing. For more news and information, you can follow us on Twitter and LinkedIn. For all our latest opportunities in the Life Science sector please click here.